Leona Plum‐Mörschel

Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus

Sue Sha, David Polidori, Tim Heise et al. · Diabetes Obesity and Metabolism · 2014 · 244 citations

Medicine, Pharmacology, Pharmacotherapy +17

Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging

Anne Flint, Grit Andersen, Paul Hockings et al. · Alimentary Pharmacology & Therapeutics · 2021 · 213 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

Inge B. Halberg, Karsten Lyby, Karsten Wassermann et al. · The Lancet Diabetes & Endocrinology · 2019 · 171 citations

Medicine, Endocrinology, Pharmacotherapy +10

Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist

Victoria E R Parker, Darren Robertson, Tao Wang et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 117 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study

Sue Sha, David Polidori, Kristin Farrell et al. · Diabetes Obesity and Metabolism · 2014 · 92 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15